Annual EBIT
-$76.33 M
-$80.32 M-2012.48%
31 December 2023
Summary:
Oncology Institute annual earnings before interest & taxes is currently -$76.33 million, with the most recent change of -$80.32 million (-2012.48%) on 31 December 2023. During the last 3 years, it has fallen by -$61.86 million (-427.56%). TOI annual EBIT is now -2012.48% below its all-time high of $8.40 million.TOI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$13.89 M
-$527.00 K-3.94%
30 September 2024
Summary:
Oncology Institute quarterly earnings before interest & taxes is currently -$13.89 million, with the most recent change of -$527.00 thousand (-3.94%) on 30 September 2024. Over the past year, it has increased by +$1.64 million (+10.57%). TOI quarterly EBIT is now -171.07% below its all-time high of $19.54 million, reached on 31 March 2022.TOI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$62.28 M
+$1.64 M+2.57%
30 September 2024
Summary:
Oncology Institute TTM earnings before interest & taxes is currently -$62.28 million, with the most recent change of +$1.64 million (+2.57%) on 30 September 2024. Over the past year, it has increased by +$5.84 million (+8.58%). TOI TTM EBIT is now -796.72% below its all-time high of $8.94 million, reached on 31 March 2022.TOI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOI EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2012.5% | +10.6% | +8.6% |
3 y3 years | -427.6% | -560.4% | -390.4% |
5 y5 years | - | -1087.1% | -5223.5% |
TOI EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -2012.5% | at low | -171.1% | +51.3% | -796.7% | +18.4% |
5 y | 5 years | -2012.5% | at low | -171.1% | +51.3% | -796.7% | +18.4% |
alltime | all time | -2012.5% | at low | -171.1% | +51.3% | -796.7% | +18.4% |
Oncology Institute EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$13.89 M(+3.9%) | -$62.28 M(-2.6%) |
June 2024 | - | -$13.36 M(-25.4%) | -$63.92 M(-2.7%) |
Mar 2024 | - | -$17.90 M(+4.5%) | -$65.72 M(-13.9%) |
Dec 2023 | -$76.33 M(-2012.5%) | -$17.13 M(+10.3%) | -$76.33 M(+12.0%) |
Sept 2023 | - | -$15.53 M(+2.4%) | -$68.12 M(+26.6%) |
June 2023 | - | -$15.16 M(-46.8%) | -$53.80 M(+22.1%) |
Mar 2023 | - | -$28.51 M(+219.5%) | -$44.06 M(-1204.0%) |
Dec 2022 | $3.99 M | -$8.92 M(+643.0%) | $3.99 M(+1037.0%) |
Sept 2022 | - | -$1.20 M(-77.9%) | $351.00 K(-163.7%) |
June 2022 | - | -$5.42 M(-127.8%) | -$551.00 K(-106.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $19.54 M(-255.5%) | $8.94 M(-179.3%) |
Dec 2021 | -$11.28 M(-22.0%) | -$12.56 M(+497.4%) | -$11.28 M(-11.2%) |
Sept 2021 | - | -$2.10 M(-151.7%) | -$12.70 M(+17.6%) |
June 2021 | - | $4.07 M(-700.6%) | -$10.80 M(-21.2%) |
Mar 2021 | - | -$677.00 K(-95.2%) | -$13.70 M(+5.2%) |
Dec 2020 | -$14.47 M(+449.1%) | -$13.99 M(+6946.4%) | -$13.03 M(-1457.5%) |
Sept 2020 | - | -$198.50 K(-117.1%) | $959.70 K(-17.1%) |
June 2020 | - | $1.16 M(-199.0%) | $1.16 M(-199.0%) |
Dec 2019 | -$2.63 M | - | - |
Dec 2018 | - | -$1.17 M | -$1.17 M |
FAQ
- What is Oncology Institute annual earnings before interest & taxes?
- What is the all time high annual EBIT for Oncology Institute?
- What is Oncology Institute annual EBIT year-on-year change?
- What is Oncology Institute quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Oncology Institute?
- What is Oncology Institute quarterly EBIT year-on-year change?
- What is Oncology Institute TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Oncology Institute?
- What is Oncology Institute TTM EBIT year-on-year change?
What is Oncology Institute annual earnings before interest & taxes?
The current annual EBIT of TOI is -$76.33 M
What is the all time high annual EBIT for Oncology Institute?
Oncology Institute all-time high annual earnings before interest & taxes is $8.40 M
What is Oncology Institute annual EBIT year-on-year change?
Over the past year, TOI annual earnings before interest & taxes has changed by -$80.32 M (-2012.48%)
What is Oncology Institute quarterly earnings before interest & taxes?
The current quarterly EBIT of TOI is -$13.89 M
What is the all time high quarterly EBIT for Oncology Institute?
Oncology Institute all-time high quarterly earnings before interest & taxes is $19.54 M
What is Oncology Institute quarterly EBIT year-on-year change?
Over the past year, TOI quarterly earnings before interest & taxes has changed by +$1.64 M (+10.57%)
What is Oncology Institute TTM earnings before interest & taxes?
The current TTM EBIT of TOI is -$62.28 M
What is the all time high TTM EBIT for Oncology Institute?
Oncology Institute all-time high TTM earnings before interest & taxes is $8.94 M
What is Oncology Institute TTM EBIT year-on-year change?
Over the past year, TOI TTM earnings before interest & taxes has changed by +$5.84 M (+8.58%)